Anavex Life Sciences Corp (AVXL)

[biotechnician]

Important Points:

1) Missling knows what they have more than we at this time.

2) The further we go into human trials in AD, PD and Rett, the more BP will need to pay.

3) Remember AD is worldwide disease, offers for AVXL will also be worldwide.

4) These CNS diseases have low bars to beat for FDA approval. No treatment for Rett, only 3 months of stabilizing AD with DPZ. Anavex already reports at least 12 month stability.

5) Imo. if Rett shows any improvement in patients we get approval. I think the drug would sell at $300,000/year per patient. If you only treat a portion of the population its a 3 BILLION DOLLAR drug.

6) Worst case scenario, in AD the drug shows only better sleep without sedation in AD and Dementia patients. With little or no side effects already established. Thats a 10 BILLION DOLLAR drug.

7) Our government alone would save trillions in health care costs if Anavex shows lengthening AD stabilitity, not curing, just stability for 12 months. ( all Missling needs to do is tweet Trump, he will have Missling at his home the next day !)